SNHG12 and neoplasm: In particular, several studies reported enhanced expression of SNHG12 in ccRCC tumors, which correlated with poor prognosis for patients, promoted viability, proliferation, migration and invasion, and inhibited apoptosis in vitro, as well as promoted ccRCC tumor growth in vivo [47,48,49].